Jennifer Robblee

Dr. Jennifer Robblee, a headache neurologist at the Barrow Neurological Institute, discusses groundbreaking migraine treatments: gepants and ditans. These new medications are reshaping acute migraine management, with fewer side effects compared to traditional triptans. The conversation highlights their effectiveness, including specific examples like ubrojapant and lasmititan. Dr. Robblee emphasizes the importance of personalized treatment plans to ensure the right therapies for individual patients, paving the way for a more innovative approach to migraine relief.

Jennifer Robblee, a board-certified neurologist and headache specialist, joins forces with Serena Orr, a pediatric neurologist, to discuss the latest 2025 guidelines on migraine treatments in emergency settings. They dive into the necessity for updates due to new evidence and ongoing practice variations. The duo emphasizes effective treatments like prochlorperazine and greater occipital nerve blocks, while warning against the use of hydromorphone. They also tackle practical implementation challenges and the need for more patient-centered research in headache management.

Dr. Jennifer Robblee and Dr. Lawrence Robbins discuss challenges in diagnosing and managing refractory headaches, debunking misconceptions and exploring treatment options like medication combinations and alternative therapies. They also highlight the importance of further research and understanding comorbidity burden in chronic migraine patients.